Suchergebnisse - (Subject:"2494G1JF75")

PubPharm (100)

1

Evaluation of super-boosted lopinavir/ritonavir in combination with rifampicin in HIV-1-infected patients with tuberculosis

enthalten in: International journal of antimicrobial agents | 2020

von Boulanger, C. | Rolla, V. | Al-Shaer, M. | +1

2

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment : A Prospective, Single-Arm Trial

enthalten in: Journal of the International Association of Providers of AIDS Care | 2019

von Claassen, C. | Keckich, D. | Nwizu, C. | +5

3

Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs

enthalten in: The Journal of antimicrobial chemotherapy | 2018

von Puertas, M. | Gómez-Mora, E. | Santos, J. | +11

4

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach : an observational analysis within the randomised, open-label, EARNEST trial

enthalten in: The lancet. HIV | 2017

von Paton, N. | Kityo, C. | Thompson, J. | +112

CommentIn: Lancet HIV. 2017 Aug;4(8):e323-e324. - PMID 28495563

5

Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial)

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Milinkovic, A. | Benn, P. | Arenas-Pinto, A. | +9

6

Cyclosporine A in addition to standard ART during primary HIV-1 infection : pilot randomized clinical trial

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Nicolás, D. | Ambrosioni, J. | Sued, O. | +15

7

Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen : a substudy of the randomised, open-label, non-inferiority SECOND-LINE study

enthalten in: The lancet. HIV | 2017

von Boyd, M. | Amin, J. | Mallon, P. | +14

CommentIn: Lancet HIV. 2017 Jun;4(6):e240. - PMID 28576610

8

Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia

enthalten in: PloS one | 2016

von Limsreng, S. | Marcy, O. | Ly, S. | +8

9

Pharmacokinetic Interactions Between Quinine and Lopinavir/Ritonavir in Healthy Thai Adults

enthalten in: The American journal of tropical medicine and hygiene | 2015

von Rattanapunya, S. | Cressey, T. | Rueangweerayut, R. | +3

10

Effect of Extra Virgin Olive Oil on Biomarkers of Inflammation in HIV-Infected Patients : A Randomized, Crossover, Controlled Clinical Trial

enthalten in: Medical science monitor : international medical journal of experimental and clinical research | 2015

von Kozić Dokmanović, S. | Kolovrat, K. | Laškaj, R. | +3

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]